5 Am Venture Management, LLC Centessa Pharmaceuticals PLC Call Options Transaction History

5 Am Venture Management, LLC

  • $251 Million
  • Q3 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

About Centessa Pharmaceuticals plc

CNTA Quotes by TradingView
  • Ticker CNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,339,296
  • Market Cap $1.43B
  • Description
  • Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...
More about CNTA
Track This Portfolio

Track 5 Am Venture Management, LLC Portfolio

Follow 5 Am Venture Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 5 Am Venture Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 5 Am Venture Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email